Zhang Ning, Wu Yishuo, Gong Jian, Li Kaiwen, Lin Xiaolin, Chen Haitao, Yu Yang, Gou Yuancheng, Hou Jiangang, Jiang Deke, Na Rong, Wang Xiang, Ding Qiang, Xu Jianfeng
Department of Urology, Huashan Hospital, Fudan University, Shanghai, PR China.
Fudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai, PR China.
Oncotarget. 2017 Apr 11;8(15):24196-24201. doi: 10.18632/oncotarget.6917.
Genome-wide association studies (GWAS) of renal cell carcinoma (RCC) have identified single nucleotide polymorphisms (SNPs) associated with RCC in European and African American population. In this study, we evaluated whether these SNPs are associated with clear cell RCC (ccRCC) in Chinese population. All reported RCC risk-associated SNPs from GWAS were evaluated in 346 ccRCC cases and 1,130 controls. Rs10054504 (at PDZD2, Odds ratio, OR = 0.71, 95%CI:0.59-0.86, P = 0.0006), rs718314 (at ITPR2, OR = 0.56, 95%CI:0.45-0.69, P = 5.26×10-8) and rs1049380 (at ITPR2, by dominant model, OR = 1.58, 95%CI:1.18-2.13, P = 0.0025) were significantly associated with ccRCC risk in Chinese population. To conclude, genetic variations in PDZD2 and ITPR2 are ccRCC-risk associated in Chinese population.
肾细胞癌(RCC)的全基因组关联研究(GWAS)已在欧洲和非裔美国人人群中鉴定出与RCC相关的单核苷酸多态性(SNP)。在本研究中,我们评估了这些SNP在中国人群中是否与透明细胞肾细胞癌(ccRCC)相关。对来自GWAS的所有已报道的RCC风险相关SNP在346例ccRCC病例和1130例对照中进行了评估。Rs10054504(位于PDZD2,比值比,OR = 0.71,95%可信区间:0.59 - 0.86,P = 0.0006)、rs718314(位于ITPR2,OR = 0.56,95%可信区间:0.45 - 0.69,P = 5.26×10-8)和rs1049380(位于ITPR2,显性模型,OR = 1.58,95%可信区间:1.18 - 2.13,P = 0.0025)与中国人群中的ccRCC风险显著相关。总之,PDZD2和ITPR2中的基因变异与中国人群中的ccRCC风险相关。